Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 205,449 | 209,361 | 188,000 | 177,757 | 181,949 |
| Cost of Goods | 77,071 | 80,190 | 79,616 | 80,433 | 83,661 |
| Gross Profit | 128,378 | 129,171 | 108,384 | 97,324 | 98,288 |
| Operating Expenses | 67,692 | 67,274 | 73,895 | 76,070 | 60,838 |
| Operating Income | 60,757 | 62,087 | 35,105 | 21,687 | 38,111 |
| Interest Expense | 19,292 | 21,767 | 20,463 | 20,790 | 22,654 |
| Other Income | -12,429 | 3,116 | 2,383 | 2,225 | 1,812 |
| Pre-tax Income | 29,036 | 43,436 | 17,025 | 3,122 | 17,269 |
| Income Tax | 12,073 | 11,929 | 5,042 | 705 | 4,733 |
| Net Income Continuous | 16,963 | 31,507 | 11,983 | 2,417 | 12,536 |
| Net Income | $16,963 | $31,507 | $11,983 | $2,417 | $12,536 |
| EPS Basic Total Ops | 0.52 | 1.00 | 0.38 | 0.08 | 0.39 |
| EPS Basic Continuous Ops | 0.53 | 1.00 | 0.38 | 0.08 | 0.39 |
| EPS Diluted Total Ops | 0.48 | 0.84 | 0.34 | 0.07 | 0.36 |
| EPS Diluted Continuous Ops | 0.40 | 0.80 | 0.31 | 0.07 | 0.32 |
| EPS Diluted Before Non-Recurring Items | 1.85 | 2.06 | 1.47 | 1.23 | 1.63 |
| EBITDA(a) | $116,899 | $118,363 | $91,449 | $77,927 | $94,247 |